Replies to post #1412 on Gilead Sciences Inc (GILD)

[Tincupx]

There were bound to be a downgrade here and there. Overall there is a pretty good upside even with HVC removed all together. This sell off is sector wide as belief of price war looms. I feel this becomes a mistake by express and a 1 and done type scenario. Everyone seems to blame gild management here but they saw this coming and there is a reason why they have even quiet. Maybe ABbV fails? Maybe CVs defends gild. Maybe express gets hammered by patients. Market reactions like this rarely play out in the long run as they seem short term

[GuTA]

Where did I say that? I asked you to do a little work on your own and not just take BOAs word for anything. I can find you any target price for any ticker looking at different analysts.

What I said was, based on what? So the company is worth tens of billions less today than it was yesterday.... Because of what exactly? Do the math. Losing 5% of hep market share while projecting to retain over 50% doesn't equate to a near 40% decrease in pps / TP or market cap. Did their treatment kill someone? Nope. Pipeline blow up? Nope. PE ratio fall apart? Nope... Was cheap at 100 and is really cheap at 90. I would need a far better reason than "BOA said so"

Trying to make a rational assessment like price target off of an irrational trading period like the last two days is itself irrational.

To answer you question: yes, I would be buying pretty much ANY company with good fundamentals and outlook like GILD once the bottom is confirmed. Especially when it's price gets hammered for a reason that is completely out of line with reduction in PPS.